Vladislav A. Mileyko

Moscow, MOW 119049, Russian Federation

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Clinical utility and implementation of a virtual molecular tumor board in real-world oncology practice.

Clinical utility and implementation of a virtual molecular tumor board in real-world oncology practice.

Journal: Cancer genetics

Published: May 12, 2026

The Role of MSI Testing Methodology and Its Heterogeneity in Predicting Colorectal Cancer Immunotherapy Response.

The Role of MSI Testing Methodology and Its Heterogeneity in Predicting Colorectal Cancer Immunotherapy Response.

Journal: International journal of molecular sciences

Published: February 27, 2025

Clinical and Morphological Features of gPALB2-Associated Breast Cancer in the Russian Population.

Clinical and Morphological Features of gPALB2-Associated Breast Cancer in the Russian Population.

Journal: Bulletin of experimental biology and medicine

Published: November 25, 2024

Analytical and Clinical Validation of Solo-Test Driver: A Targeted Amplicon-Based NGS Test-System for FFPE and cfDNA Analysis in Clinical Oncology Setting.

Analytical and Clinical Validation of Solo-Test Driver: A Targeted Amplicon-Based NGS Test-System for FFPE and cfDNA Analysis in Clinical Oncology Setting.

Journal: Journal of clinical laboratory analysis

Published: October 18, 2024

Adaptation of PCR-based library preparation for MGI platform for cancer mutation testing in clinical setting.

Adaptation of PCR-based library preparation for MGI platform for cancer mutation testing in clinical setting.

Journal: PloS one

Published: September 23, 2024

Multi-Institutional Evaluation of Interrater Agreement of Biomarker-Drug Pair Rankings Based on the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT) and Sources of Discordance.

Multi-Institutional Evaluation of Interrater Agreement of Biomarker-Drug Pair Rankings Based on the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT) and Sources of Discordance.

Journal: Molecular diagnosis & therapy

Published: September 22, 2024

Dynamics of blood microsatellite instability (bMSI) burden predicts outcome of a patient treated with immune checkpoint inhibitors: a case report of hyperprogressive disease.

Dynamics of blood microsatellite instability (bMSI) burden predicts outcome of a patient treated with immune checkpoint inhibitors: a case report of hyperprogressive disease.

Journal: Frontiers in immunology

Published: September 06, 2024

Failure of immune checkpoint inhibitors for microsatellite instability-positive pancreatic adenocarcinoma with atypical pattern of short tandem repeat mutation.

Failure of immune checkpoint inhibitors for microsatellite instability-positive pancreatic adenocarcinoma with atypical pattern of short tandem repeat mutation.

Journal: Immunotherapy

Published: July 23, 2024

Evaluation of blood MSI burden dynamics to trace immune checkpoint inhibitor therapy efficacy through the course of treatment.

Evaluation of blood MSI burden dynamics to trace immune checkpoint inhibitor therapy efficacy through the course of treatment.

Journal: Scientific reports

Published: June 18, 2024

Untapped Potential of Poly(ADP-Ribose) Polymerase Inhibitors: Lessons Learned From the Real-World Clinical Homologous Recombination Repair Mutation Testing.

Untapped Potential of Poly(ADP-Ribose) Polymerase Inhibitors: Lessons Learned From the Real-World Clinical Homologous Recombination Repair Mutation Testing.

Journal: World journal of oncology

Published: January 17, 2024

Impact of the STK11/KRAS co-mutation on the response to immunotherapy in a real-world pan-cancer cohort.

Impact of the STK11/KRAS co-mutation on the response to immunotherapy in a real-world pan-cancer cohort.

Journal: Tumori

Published: October 11, 2023

Precision oncology strategy in cetuximab-resistant ERRFI1-mutant colon cancer: case report of disease progression on afatinib.

Precision oncology strategy in cetuximab-resistant ERRFI1-mutant colon cancer: case report of disease progression on afatinib.

Journal: American journal of translational research

Published: July 05, 2023

Showing 1-12 of 25

Last Updated: 09/26/2026